Pharma and Biotech
Publication of a Prospectus | 21-May-2025 | 15:24 | RNS |
Result of placing | 16-May-2025 | 07:31 | RNS |
Proposed equity fundraising via ABB | 15-May-2025 | 16:53 | RNS |
Result of General Meeting | 28-Apr-2025 | 11:30 | RNS |
Proposed acquisition of Awakn approved | 23-Apr-2025 | 07:00 | RNS |
Final Results for the year ended 31 December 2024 | 16-Apr-2025 | 07:00 | RNS |
Posting of Circular and Notice of General Meeting | 10-Apr-2025 | 14:00 | RNS |
Holding(s) in Company | 07-Apr-2025 | 07:00 | RNS |
Engagement of PharmaVentures | 04-Apr-2025 | 07:00 | RNS |
Positive progress on European Patent Application | 26-Mar-2025 | 07:00 | RNS |
Update on AWKN-SDN-14 programme | 18-Mar-2025 | 07:00 | RNS |
Holding(s) in Company | 11-Mar-2025 | 09:00 | RNS |
Appointment of Non-Executive Director | 11-Mar-2025 | 07:00 | RNS |
Entry into an Arrangement Agreement with Awakn | 24-Feb-2025 | 07:00 | RNS |
Update on Awakn Life Sciences’ R&D Progress | 27-Jan-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.13p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1.01 |
52 Week Low | 0.12 |
Volume | 48,383,268 |
Shares Issued | 2,295.93m |
Market Cap | £3.04m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
13:32 | 2,278,298 @ 0.13p |
10:22 | 56,387 @ 0.13p |
09:50 | 183,110 @ 0.13p |
08:13 | 56,282 @ 0.13p |
08:13 | 1,274 @ 0.13p |
CEO | Anthony Tennyson |
Chair | Dennis Purcell |
Finance Director | Ryan Neats |
You are here: research